Skip to content
Clinical Trials – home
Fundacio Sant Joan De Deu
Sponsor

Fundacio Sant Joan De Deu

Spain Calle Santa Rosa 39-57 3a Planta, 08950 Esplugues De Llobregat, Spain

About the sponsor

Fundacio Sant Joan De Deu supports clinical research in aggressive childhood cancers, with particular interest in acute lymphoblastic leukemia, neuroblastoma, and diffuse intrinsic pontine glioma. The funded studies include advanced CAR-T cell approaches, immunotherapy, and treatment strategies for difficult-to-treat paediatric malignancies.

  • CD19+ acute lymphoblastic leukemia
  • High-risk neuroblastoma
  • Diffuse intrinsic pontine glioma
  • Anti-IL13Ra2 CAR-T cells
  • Dendritic cell immunisation

Its oncology portfolio also includes research on refractory paediatric leukaemia and tumour-directed immunotherapies for newly diagnosed and treatment-resistant disease.

About Specializations

Fundacio Sant Joan De Deu runs clinical trials in conditions such as Neuroblastoma, Brain stem glioma, Cardiomyopathy, Vascular malformation, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

8 clinical trials

Neuroblastoma

Recruiting

Naxitamab Added to Standard Induction Therapy for Children and Teenagers with Newly Diagnosed High-Risk Neuroblastoma

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years
  • Substances:Naxitamab
  • Sponsor:Fundacio Sant Joan De Deu

Testing the Safety of Dendritic Cell and CAR-T Cell Combination Therapy in Patients with Newly Diagnosed Diffuse Intrinsic Pontine Glioma

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years
  • Substances:ARI0008
  • Sponsor:Fundacio Sant Joan De Deu

Cardiomyopathy

Recruiting

A Study Comparing Gadopiclenol and Gadoterate Meglumine for Heart MRI Scans in Children with Congenital Heart Disease

Registered drugNo placebo
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years
  • Substances:Meglumine Gadoterate
  • Sponsor:Fundacio Sant Joan De Deu

Evaluation of Enoxaparin for Prevention of Localized Intravascular Coagulopathy in Children with Slow-Flow Vascular Malformations Undergoing Interventional Procedures

Registered drugNo placebo
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years
  • Substances:Enoxaparin Sodium
  • Sponsor:Fundacio Sant Joan De Deu
Countries:SpainSpain
  • Participants:18–64 years
  • Substances:Sildenafil
  • Sponsor:Fundacio Sant Joan De Deu

Cerebellar ataxia

Not yet recruiting

Study on the Effects of Ubiquinol and Ascorbic Acid for Patients with Mitochondrial Disorders and Cerebellar Ataxias

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Ascorbic Acid
  • Sponsor:Fundacio Sant Joan De Deu

Study of ARI-0001 Cells for Children and Adolescents with Resistant or Refractory Acute Lymphoblastic Leukemia

Registered drugNo placebo
Countries:SpainSpain
  • Participants:0–17 years
  • Substances:Allopurinol
  • Sponsor:Fundacio Sant Joan De Deu

Study on the Effects of Spironolactone, Pioglitazone, and Metformin for Adolescent Girls and Young Women with Polycystic Ovary Syndrome (PCOS)

Investigational
Countries:AustriaAustria
  • Participants:0–17 years · 18–64 years
  • Substances:Metformin
  • Sponsor:Fundacio Sant Joan De Deu

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.